Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 37.4% | 51.7% | 42.7% | – |
| Gross Profit | £0 | £0 | £0 | -£0 |
| % Margin | 37.1% | 60% | 34.7% | -184.4% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -37% | -14.9% | -69.5% | -704.7% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -40.5% | -20.7% | -85.8% | -750% |
| EPS Diluted | -0.009 | -0.004 | -0.011 | -0.073 |
| % Growth | -121.4% | 63.2% | 84.4% | – |
| Operating Cash Flow | -£0 | -£0 | £0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | £0 | -£0 |